We may earn a commission for purchases made using our links.

Samsung has announced that it has received clearance for the ECG function in Samsung Health Monitor app by South Korea’s Ministry of Food and Drug Safety (MFDS). What this means is that the ECG sensor on the Galaxy Watch Active 2 can now be used for analyzing heart rhythm for abnormalities such as Atrial Fibrillation (AFib).

AFib is among the leading causes for strokes, and also increases the risk of complications such as blood clots and heart failure among others. However, it must be noted that the ECG monitoring feature is limited to the Galaxy Watch Active 2 via the Samsung Health Monitor app. However, it will likely be available on its successors too.

A month ago, the Samsung Health Monitor app too was cleared by MFDS for monitoring blood pressure, classifying it as a “Software as a Medical Device (SaMD)” product. Thanks to the nod from the regulatory body, the Galaxy Watch Active 2 could be marketed as a government-cleared, cuff-less device for monitoring blood pressure levels.

Source: Samsung

You May Also Like
The latest Mac mini, and more Apple products are on sale today
Today’s deals include the latest Apple Mac mini, Apple’s Airpods, Toshiba’s Fire TV Edition Smart TV and more
Samsung Galaxy Watch 3
Samsung Galaxy Watch 3 support page goes live, launch imminent
The products that seem to be India-bound bear the model numbers SM-R845F and SM-R850.
Polar Unite smartwatch arrives with a less boring design and $150 price tag
Polar says its new smartwatch can last up to 4 days in watch mode on a single charge and up to 50 hours in training mode with GPS enabled